Unique ID issued by UMIN | UMIN000056681 |
---|---|
Receipt number | R000064761 |
Scientific Title | A Study on the Effect of Test Substance P on Body Fat Reduction -Open Study- |
Date of disclosure of the study information | 2025/01/10 |
Last modified on | 2025/01/08 09:18:16 |
A Study on the Effect of Test Substance P on Body Fat Reduction -Open Study-
A Study on the Effect of Test Substance P on Body Fat Reduction
A Study on the Effect of Test Substance P on Body Fat Reduction -Open Study-
A Study on the Effect of Test Substance P on Body Fat Reduction
Japan |
No
Adult |
Others
NO
To confirm the effect of test substance P on body fat
Efficacy
Body weight(BMI), and body fat percentage(mass) after 12 weeks
Other indexes related to body composition after 12 weeks
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Other |
12-week intervention of test substance P
20 | years-old | <= |
65 | years-old | > |
Male and Female
(1)Healthy males and females aged 20 to 64 years-old.
(2)Subjects whose BMI are 18.5 or over and under 30.
(3)Subjects who can make self-judgment and are voluntarily giving written informed consent.
Subjects (who)
(1) have a chronic disease and use medications affecting obesity, muscle, glucose and lipid metabolism.
(2)contract serious diseases (eg, liver disease, kidney disease, digestive disease, heart disease, respiratory disease, endocrine disorders, blood circulation disorders, and/or metabolic disease, diseases of the locomotive organs).
(3)can't stop using supplements and/or functional foods (including Food for Specified Health Uses or Foods with Function Claims) affecting obesity during test periods.
(4)have physical activity affected, or undergoing or scheduled to undergo treatment for locomotive organs.
(5)are not constitutionally suited to the test substance P.
(6)can't stop drinking from 2 days before each measurement.
(7)are judged as unsuitable for the current study by the investigator ased on the interview and vitals conducted during the screening test.
(8)have excessive alcohol intake more than 20 g/day of pure alcohol equivalent for more than 4 days a week.
(9)are under treatment for or have a history of drug addiction and/or alcoholism.
(10)are shift worker, midnight-shift worker, and/or subjects with extremely irregular dietary or exercise habits.
(11)are pregnant or planning to become pregnant or breastfeed during the study period.
(12)are participating in or willing to participate in other clinical studies using other foods, drugs, health appliances, or the application of cosmetics.
(13)are judged as unsuitable for the current study by the investigator for other reasons.
40
1st name | Daisuke |
Middle name | |
Last name | Tsuge |
Shinagawa Season Terrace Health Care Clinic
Doctor
108-0075
1-2-70, Konan, Minato-ku, Tokyo The 5th floor of Shinagawa season terrace
03-3452-3382
shibaura@sempos.or.jp
1st name | Yoshika |
Middle name | |
Last name | Komori |
KSO Corporation
Clinical Trial Management department
105-0023
1-9-7 Shibaura, Minato-ku, Tokyo
03-3452-7733
eigyou27@kso.co.jp
KSO Corporation
TOYO SHINYAKU Co., Ltd.
Profit organization
Ethical Committee of Kobuna Orthopedics Clinic
5-656-17 Joto-machi, Maebashi-shi, Gunma
027-212-5608
sagawa@mc-connect.co.jp
NO
2025 | Year | 01 | Month | 10 | Day |
Unpublished
Preinitiation
2024 | Year | 11 | Month | 08 | Day |
2025 | Year | 01 | Month | 11 | Day |
2025 | Year | 04 | Month | 30 | Day |
2025 | Year | 01 | Month | 10 | Day |
2025 | Year | 01 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064761